Movatterモバイル変換


[0]ホーム

URL:


CN103271794A - Biological antibacterial patch for bedsore surface - Google Patents

Biological antibacterial patch for bedsore surface
Download PDF

Info

Publication number
CN103271794A
CN103271794ACN2013102405559ACN201310240555ACN103271794ACN 103271794 ACN103271794 ACN 103271794ACN 2013102405559 ACN2013102405559 ACN 2013102405559ACN 201310240555 ACN201310240555 ACN 201310240555ACN 103271794 ACN103271794 ACN 103271794A
Authority
CN
China
Prior art keywords
biological
plaster
bedsore
wound
biological antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013102405559A
Other languages
Chinese (zh)
Other versions
CN103271794B (en
Inventor
徐云龙
钱秀珍
徐霏霏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEINA TECH Co Ltd SHANGHAI
Original Assignee
WEINA TECH Co Ltd SHANGHAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEINA TECH Co Ltd SHANGHAIfiledCriticalWEINA TECH Co Ltd SHANGHAI
Priority to CN201310240555.9ApriorityCriticalpatent/CN103271794B/en
Publication of CN103271794ApublicationCriticalpatent/CN103271794A/en
Application grantedgrantedCritical
Publication of CN103271794BpublicationCriticalpatent/CN103271794B/en
Expired - Fee Relatedlegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Images

Landscapes

Abstract

The invention relates to a biological antibacterial patch for bedsore surface. The composite film patch mainly comprises four layers, namely a bottom breathable base (1) coated with adhesive, a second layer made of nonwoven rayon (2), a third layer made of biological antibacterial dressing (3), and a surface paper isolation layer (4), wherein one end of the bottom breathable base is provided with an easy tear edge (5). The biological antibacterial dressing is made from chitosan, acetic acid, lysozyme, gelatin, clorhexidine acetate, aerosil, and water. The biological bacterial dressing including no any additive has the functions of fine antibiosis, inflammation diminishing, hemostasis, promoting cell growth, promoting wound healing and the like, and has the advantages of high water content, fine water retention, high toughness and good breathability. The biological antibacterial patch for bedsore surface is mainly used for treating bedsores, burns and surgical infections.

Description

Apply ointment or plaster based on the biological antibiotic that bedsore wound is used
Technical field
The present invention relates to a kind of biological antibiotic of using based on bedsore wound and apply ointment or plaster and its production and use, particularly a kind of antibiotic applying ointment or plaster of natural biological of containing the treatment decubital ulcer of chitosan.
Background technology
Decubital ulcer is a kind of common exogenous injury of human body, and decubital ulcer not only causes the damage of skin, and can cause serious systemic reaction, large tracts of land decubital ulcer especially, and general reaction is particularly violent, so early stage correct processing of bedsore wound is the key measure of protecting from infection.
Mainly be to use dry gauze or the wrapping of oily yarn for decubitus wound conventional process way.Dry gauze only plays the effect that supervision covers wound.And wound healing is not had facilitation, and sepage management is limited in one's ability, and the adhesion wound, and newborn epithelial tissue is damaged and causes hemorrhagely, and patient is pain behind the change dressings more.Though oil yarn adhesion wound does not have facilitation to the whole agglutination of wound, invalid to infected wound, the sepage management is limited in one's ability.
The biological antibiotic compound film dressing is a kind of novel wound dressing that development in recent years is got up, compare with used traditional dressing at present etc., aerogel dressing can shorten the time of wound healing, alleviate patient's pain, promote that wound better heals, and air permeable humidity retaining can not destroy the wound tissue of having healed when change dressings more.And material self physics and stable chemical performance are easily preserved.
Summary of the invention
The technical issues that need to address of the present invention are based on the biological antibiotic that bedsore wound uses and apply ointment or plaster, especially at the treatment of degree of depth bedsore wound.
It is strong that a kind of biological antibiotic compound film dressing of the present invention has water absorption, and moisture retention is good, the intensity height, pliability is good, characteristics such as permeability is good, and have antibioticly, can absorb transudate, ventilative, not with the tissue adhesion, antiinflammatory, effects such as hemostasis and promotion wound healing, be that preparation is simple, a kind of biological antibiotic compound film dressing that cost is low.
Technical scheme of the present invention:
Biological antibacterial dressing of the present invention comprises: the biological antibacterial dressing compositions of the gel form for the treatment of effective dose, earlier the biological antibacterial dressing compositions is coated on the nonwoven artificial silk during its preparation, and add ventilative base material and sealing coat then.
Described biological antibacterial dressing combination has:
(a) chitosan: 2~94.445%,
(b) acetic acid: 0.2~5%,
(c) lysozyme: 0.1~25%,
(d) gelatin: 5~20%,
(e) aerosil: 0.25%~4%,
(f) chlorhexidine acetate: 0.005%~0.375%,
(g) water: 0~92.445%.
Above-mentioned biological antibacterial dressing prepares by the following method:
A certain amount of chitosan is dissolved in certain density acetic acid, makes solution a; A certain amount of lysozyme is dissolved in a certain amount of deionized water, makes solution b; Solution a and solution b are mixed stirring, and liquid is uniformly mixed; In mixed liquor, add a certain amount of gelatin, aerosil and chlorhexidine acetate again; Then this biological antibacterial dressing direct part is dewatered or is applied on the carrier nonwoven artificial silk and dewater again, be placed on the rolling cut ad-hoc location on the packer of applying ointment or plaster with scribbling the ventilative base material of binding agent and artificial no spinning that the papery sealing coat has been coated with biological antibacterial dressing in addition, open the rolling cut packer of applying ointment or plaster, with the product excision forming, sterile packaged is preserved.
Foundation of the present invention: by chitosan combination degradation technique, chitosan, degradation of chitosan product and lysozyme are carried out organic complex, reach Synergistic biocidal potentiation purpose; Utilize preserving moisture and film forming characteristics of chitosan, and the nutritional support that provides of gelatin, further promote wound healing and suppress the cicatrix growth; Utilize the lysozyme degradation technique, suppress the oxidation of product in preparation process, keep the activity of biomaterial.
Said chitosan is the derivant of chitin after refining, deacetylated.
Above-mentioned lysozyme is a kind of in staphylococcus lysozyme, endogenous or the exogenous lysozyme or their compound enzyme.
Used chlorhexidine acetate is cationic surfactant, has has a broad antifungal spectrum, characteristics that antibacterial action is stronger, and most Grain-positives and negative bacteria are had killing action.Onset is rapid, effect is lasting; Absorbed by body hardly, therefore have no side effect, life-time service does not develop immunity to drugs.
Acetic acid is mainly used to dissolve chitosan.
Aerosil is a kind of extremely fine nano-scale amorphous fumed silica, and particle diameter is little, even particle size distribution, specific surface area are big, has very high surface activity.The present invention adds fumed silica in prescription, not only effectively thickening, improve product stability, and can improve the thixotropic property of product and the skin sense when using.
Gelatin has the performance that promotes cell adhesion and growth, has good affinity with biological tissue, and it has activated macrophage and hemostatic function, is therefore often made to make wound dressing separately or with other materials is compound.
Polyurethane film is fine porous structure, can only see through the water vapour molecule that particle diameter is about 0.4nm, and to any water droplet, can't pass through because particle diameter is excessive, also intercepting extraneous water when therefore playing the antiseepage effect enters, can allow the steam of body surface evaporation and transudate can be smoothly by and vapor away, and can guarantee that wound is ventilative.If transudate is too much, artificial no spinning (3) can absorb a large amount of transudates, and can keep the moist environment of wound appropriateness, for wound provides better healing environment.
When this biological antibacterial dressing is attached to wound, can kill the various common clinical bacterium of wound fast, form layer protecting film at wound surface simultaneously, have the control traumatic infection, promote wound healing and suppress cicatrix growth effect.
Description of drawings
The invention will be further described below in conjunction with the drawings and specific embodiments.
Accompanying drawing is structural representation of the present invention.
Among the figure, 1. scribble the ventilative base material of binding agent, 2. nonwoven artificial silk, 3. biological antibacterial dressing, 4. papery sealing coat, 5. easy-to-draw corner.
The specific embodiment:
A kind of biological antibiotic composite membrane of the present invention applies schematic cross-sectional view as shown in drawings, comprises that 1. scribble the ventilative base material of binding agent, 2. nonwoven artificial silk, 3. biological antibacterial dressing, 4. papery sealing coat, 5. easy-to-draw corner.
By chitosan, glacial acetic acid, lysozyme, chlorhexidine acetate, deionized water, gelatin, also has silicon dioxide etc., the biologicalantibacterial dressing 3 that makes overlays in the artificial nospinning 2, and theventilative base material 1 that scribbles binding agent is coating artificial nospinning 2 and biologicalantibacterial dressing 3 withpapery sealing coat 4.
The present invention applies ointment or plaster when using, and tears papery sealing coat (4) off from easy-to-draw corner (5), biological antibacterial dressing (3) is adjacent to towards wound get final product.
Embodiment 1-7:
Prepare biological antibacterial dressing according to following ratio:
?1234567
Chitosan2468101214
Lysozyme2222234
Gelatin2468101214
Aerosil0.250.250.250.250.250.350.5
Chlorhexidine acetate0.050.050.10.10.111
The biological antibacterial dressing of above-described embodiment to the sterilizing rate of escherichia coli, bacillus pyocyaneus, golden staphylococci, Candida albicans all greater than 90%.

Claims (4)

CN201310240555.9A2013-06-172013-06-17Biological antibiotic based on bedsore wound is applied ointment or plasterExpired - Fee RelatedCN103271794B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201310240555.9ACN103271794B (en)2013-06-172013-06-17Biological antibiotic based on bedsore wound is applied ointment or plaster

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201310240555.9ACN103271794B (en)2013-06-172013-06-17Biological antibiotic based on bedsore wound is applied ointment or plaster

Publications (2)

Publication NumberPublication Date
CN103271794Atrue CN103271794A (en)2013-09-04
CN103271794B CN103271794B (en)2015-08-05

Family

ID=49054022

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201310240555.9AExpired - Fee RelatedCN103271794B (en)2013-06-172013-06-17Biological antibiotic based on bedsore wound is applied ointment or plaster

Country Status (1)

CountryLink
CN (1)CN103271794B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN104474536A (en)*2014-11-192015-04-01周清华Fresh agrimonia pilosa medicine preparation for treating wounds
CN105256650A (en)*2015-10-052016-01-20福建农林大学Multifunctional nanocellulose supported lactic acid/chitosan drug-loaded nano microsphere paper-making paint and preparing method thereof
CN105770973A (en)*2016-03-142016-07-20苏州市贝克生物科技有限公司Preparation method of medical biological dressing for bedsores
CN106729939A (en)*2016-12-292017-05-31河南亚都实业有限公司A kind of dressing for treating bedsore
WO2017088227A1 (en)*2015-11-282017-06-01深圳市前海康启源科技有限公司Novel bio-functionalized wound dressing based on fibroin
CN108096224A (en)*2017-12-302018-06-01张静A kind of infantile umbilical paste
CN109700601A (en)*2019-02-022019-05-03天津嘉氏堂科技有限公司A kind of hydrocolloid silicon dressing patch
CN110743082A (en)*2019-11-222020-02-04中国医学科学院血液病医院(中国医学科学院血液学研究所) A kind of chlorhexidine gluconate antibacterial transparent dressing
CN111511413A (en)*2017-12-212020-08-07汉阳大学校产学协力团 Hydrocolloid composition and biopatch comprising the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JP2006249025A (en)*2005-03-112006-09-21Nipro Corp Pressure ulcer treatment pad
CN101301487A (en)*2008-06-242008-11-12上海硅健生物材料有限公司Gelatine/biological activity glass composite sponge dressing and preparation thereof
CN101461960A (en)*2007-12-182009-06-24王淑琳Bedsore biological dressing
CN201888953U (en)*2010-11-102011-07-06广东百合医疗科技有限公司Fiber type wound dressing with antibacterial effect

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JP2006249025A (en)*2005-03-112006-09-21Nipro Corp Pressure ulcer treatment pad
CN101461960A (en)*2007-12-182009-06-24王淑琳Bedsore biological dressing
CN101301487A (en)*2008-06-242008-11-12上海硅健生物材料有限公司Gelatine/biological activity glass composite sponge dressing and preparation thereof
CN201888953U (en)*2010-11-102011-07-06广东百合医疗科技有限公司Fiber type wound dressing with antibacterial effect

Cited By (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN104474536A (en)*2014-11-192015-04-01周清华Fresh agrimonia pilosa medicine preparation for treating wounds
CN105256650A (en)*2015-10-052016-01-20福建农林大学Multifunctional nanocellulose supported lactic acid/chitosan drug-loaded nano microsphere paper-making paint and preparing method thereof
WO2017088227A1 (en)*2015-11-282017-06-01深圳市前海康启源科技有限公司Novel bio-functionalized wound dressing based on fibroin
CN105770973A (en)*2016-03-142016-07-20苏州市贝克生物科技有限公司Preparation method of medical biological dressing for bedsores
CN106729939A (en)*2016-12-292017-05-31河南亚都实业有限公司A kind of dressing for treating bedsore
CN111511413A (en)*2017-12-212020-08-07汉阳大学校产学协力团 Hydrocolloid composition and biopatch comprising the same
CN111511413B (en)*2017-12-212022-11-22汉阳大学校产学协力团 Hydrocolloid composition and biopatch comprising the hydrocolloid composition
CN108096224A (en)*2017-12-302018-06-01张静A kind of infantile umbilical paste
CN109700601A (en)*2019-02-022019-05-03天津嘉氏堂科技有限公司A kind of hydrocolloid silicon dressing patch
CN110743082A (en)*2019-11-222020-02-04中国医学科学院血液病医院(中国医学科学院血液学研究所) A kind of chlorhexidine gluconate antibacterial transparent dressing

Also Published As

Publication numberPublication date
CN103271794B (en)2015-08-05

Similar Documents

PublicationPublication DateTitle
CN103271794B (en)Biological antibiotic based on bedsore wound is applied ointment or plaster
Rezvani Ghomi et al.Wound dressings: Current advances and future directions
US10463760B2 (en)Absorbent, breathable and pathogen blocking/killing wound care dressing and fabrication thereof
Lionelli et al.Wound dressings
Hanna et al.A review of wound healing and wound dressing products
Martin et al.Current trends in the development of wound dressings, biomaterials and devices
BR112019012079B1 (en) MULTI-LAYER WOUND CARE PRODUCT
US20040127826A1 (en)Honey in wound dressings
EA010316B1 (en)Wound dressing based on microbial-derived cellulose, use thereof and kit containing thereof
CN110507845A (en)Biological composite ventilating dressing and preparation method thereof
Dave et al.Biomedical evaluation of a novel nitrogen oxides releasing wound dressing
CN203576752U (en)Novel calcium-alginate povidone-iodine-powder spunlaced non-woven fabrics dressing
RU2437681C1 (en)Wound covering with therapeutic action
JP6290184B2 (en) Wound dressing
HanInteractive wound dressings
CN106344954A (en)Bio-antimicrobial bacterial cellulose dressing and preparation method thereof
Sonar et al.A comprehensive review on wound dressing usage in clinical settings
JacobsenUpdate on wound dressings: indications and best use
JP4486304B2 (en) Microbial cellulosic wound dressings for the treatment of chronic wounds
CN204814415U (en)Antibiotic woundplast
CN104622643A (en)Medical negative-pressure adsorption dressing and application thereof
ThomasA guide to dressing selection
CN112426562A (en)Pure natural medical dressing for promoting wound healing
CN208926800U (en) A kind of medical ozone oil dressing sticker
CN110755673A (en)Sodium carboxymethylcellulose liquid dressing and preparation method thereof

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C14Grant of patent or utility model
GR01Patent grant
CF01Termination of patent right due to non-payment of annual fee

Granted publication date:20150805

Termination date:20170617

CF01Termination of patent right due to non-payment of annual fee

[8]ページ先頭

©2009-2025 Movatter.jp